Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP256700.RARGMrsK2U7Cicd8L3p8UV8iYpbzyZESgsP9nZ2mmNbK0130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256700.RARGMrsK2U7Cicd8L3p8UV8iYpbzyZESgsP9nZ2mmNbK0130_provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP843927.RAQV9-Q26AH88sRKKrBYAa5H0hjFhsM5X_zu1RwbRjmxU130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843927.RAQV9-Q26AH88sRKKrBYAa5H0hjFhsM5X_zu1RwbRjmxU130_provenance.
• NP1016954.RAWXQPnggg8ola3KwPXjh0_LeanLWw2M0WGoALAJ6ViQA130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016954.RAWXQPnggg8ola3KwPXjh0_LeanLWw2M0WGoALAJ6ViQA130_provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1126095.RARHeTQldFT2yWht3AF3OHrNZbG_R8rB9UsH_o4KKn628130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126095.RARHeTQldFT2yWht3AF3OHrNZbG_R8rB9UsH_o4KKn628130_provenance.
• NP1126097.RAYy73Hi7lPtuQS5xx2J_plFXmrVprUtjX2J1x4jDDuWA130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126097.RAYy73Hi7lPtuQS5xx2J_plFXmrVprUtjX2J1x4jDDuWA130_provenance.
• NP1126093.RAAx66JLVwz7tIBN5e80fjm0OJZwYdNQ5pArLI71o13ks130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126093.RAAx66JLVwz7tIBN5e80fjm0OJZwYdNQ5pArLI71o13ks130_provenance.
• NP849445.RAiipgrJ3PqTOJO-YWmLpCso4egb6rHzkD3AttWg1eol8130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849445.RAiipgrJ3PqTOJO-YWmLpCso4egb6rHzkD3AttWg1eol8130_provenance.
• NP849482.RAtFXxrIBZtTGKe0RBOB3wmN_nW2TyWlxsVKAe6qdG2Uo130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849482.RAtFXxrIBZtTGKe0RBOB3wmN_nW2TyWlxsVKAe6qdG2Uo130_provenance.
• NP1126087.RAhMzYZhStdNCNeUyoREziETSiX-yELXCqGGXDA7F-mX4130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126087.RAhMzYZhStdNCNeUyoREziETSiX-yELXCqGGXDA7F-mX4130_provenance.
• NP1126088.RArBbTl1zHlJE-jXk46mx3vXuSI05uuLCTPfH5BlbDSDk130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126088.RArBbTl1zHlJE-jXk46mx3vXuSI05uuLCTPfH5BlbDSDk130_provenance.
• NP1126091.RAnNMY-2126ZoMcnHuuib8TKzOX2nTf_2wN9WYHKAd7u8130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126091.RAnNMY-2126ZoMcnHuuib8TKzOX2nTf_2wN9WYHKAd7u8130_provenance.
• NP1016974.RAndA9gOGovMWN183m8oI7pAOc7PQNI6uRaoL2pgmD8tM130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016974.RAndA9gOGovMWN183m8oI7pAOc7PQNI6uRaoL2pgmD8tM130_provenance.
• NP256712.RA0yn7bgFn9TO7szzMEXvKSwsodXqvt6z2jgalr-xVpLM130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256712.RA0yn7bgFn9TO7szzMEXvKSwsodXqvt6z2jgalr-xVpLM130_provenance.
• NP584722.RA85RP3BKXGIFkLLLYgOGu7pieEso1vrO1tyBhBm65zfY130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584722.RA85RP3BKXGIFkLLLYgOGu7pieEso1vrO1tyBhBm65zfY130_provenance.
• NP584723.RA7l1FCbeH2SS3aFCdl8lrzzFy5EpVg1s59T1SJrylLhk130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584723.RA7l1FCbeH2SS3aFCdl8lrzzFy5EpVg1s59T1SJrylLhk130_provenance.
• NP1126086.RAL16t3WSu8FY351GbreJOM1TH3Y0cO7R0Vvhp2dqO568130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126086.RAL16t3WSu8FY351GbreJOM1TH3Y0cO7R0Vvhp2dqO568130_provenance.
• NP1126089.RAEiwVlKxzs3jbRWH-IRNV9mb68eEgpy96rkp30BQ1hSk130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126089.RAEiwVlKxzs3jbRWH-IRNV9mb68eEgpy96rkp30BQ1hSk130_provenance.
• NP1126096.RAEHW8uid6lGtXmCyctY1YKYUET8Y92sTz0uosWBLBkeg130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126096.RAEHW8uid6lGtXmCyctY1YKYUET8Y92sTz0uosWBLBkeg130_provenance.
• NP843814.RA49WyT5eZ3dZS-sre4OrZsncKv-kM2yuvHcYOVWlZz-o130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843814.RA49WyT5eZ3dZS-sre4OrZsncKv-kM2yuvHcYOVWlZz-o130_provenance.
• NP1126092.RA4q_3T_g8Ta2ZjDmeS-geZ4ki3DmYLwLMwWnGVXoxmsw130_assertion description "[Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126092.RA4q_3T_g8Ta2ZjDmeS-geZ4ki3DmYLwLMwWnGVXoxmsw130_provenance.